161
Views
8
CrossRef citations to date
0
Altmetric
Research Article

Protection against tacrolimus-induced cardiotoxicity in rats by olmesartan and aliskiren

, , , , , , & show all
Pages 697-702 | Received 10 Jul 2014, Accepted 06 Sep 2014, Published online: 23 Sep 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Articles from other publishers (7)

Jakub Mizera, Justyna Pilch, Ugo Giordano, Magdalena Krajewska & Mirosław Banasik. (2023) Therapy in the Course of Kidney Graft Rejection—Implications for the Cardiovascular System—A Systematic Review. Life 13:7, pages 1458.
Crossref
Saeed Alshahrani. (2020) Aliskiren – A promising antioxidant agent beyond hypertension reduction. Chemico-Biological Interactions 326, pages 109145.
Crossref
Louise E See Hoe, Nicole Bartnikowski, Matthew A Wells, Jacky Y Suen & John F Fraser. (2019) Hurdles to Cardioprotection in the Critically Ill. International Journal of Molecular Sciences 20:15, pages 3823.
Crossref
Matthias Pinter, Wilhelmus J. Kwanten & Rakesh K. Jain. (2018) Renin–Angiotensin System Inhibitors to Mitigate Cancer Treatment–Related Adverse Events. Clinical Cancer Research 24:16, pages 3803-3812.
Crossref
G.L. Alonso Salinas & J.L. Zamorano Gómez. 2017. Anti-Cancer Treatments and Cardiotoxicity. Anti-Cancer Treatments and Cardiotoxicity 339 341 .
Faisal Imam, Naif O. Al-Harbi, Mohammed M. Al-Harbia, Hesham M. Korashy, Mushtaq Ahmad Ansari, Mohamed M. Sayed-Ahmed, Mahmoud N. Nagi, Muzaffar Iqbal, Md. Khalid Anwer, Imran Kazmi, Muhammad Afzal & Saleh Bahashwan. (2015) Rutin Attenuates Carfilzomib-Induced Cardiotoxicity Through Inhibition of NF-κB, Hypertrophic Gene Expression and Oxidative Stress. Cardiovascular Toxicology 17:1, pages 58-66.
Crossref
Abeer A. I. Sharaf El-Din & Omaima M. Abd Allah. (2016) Impact of Olmesartan Medoxomil on Amiodarone-Induced Pulmonary Toxicity in Rats: Focus on Transforming Growth Factor-ß1. Basic & Clinical Pharmacology & Toxicology 119:1, pages 58-67.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.